Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 7c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.97), $0.07 better than the analyst estimate of ($2.04).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Yen Jumps More Than 1% To Trade At 158.22 Per Us Dollar
• EXL president Vivek Jetley to depart for Hexaware CEO role
• Advent International proposes $1.02-per-share buyout of Definitive Healthcare